Literature DB >> 6175043

Antithrombin BM from human plasma: an antithrombin binding moderately to heparin.

P Wunderwald, W J Schrenk, H Port.   

Abstract

A human antithrombin was purified app. 60 fold from Cohn fraction IV, to give a single band of about 70.000 molecular weight in polyacrylamide gel electrophoresis. Compared to the similar antithrombin III, this glycoprotein binds only moderately to porcine heparin (hence its name Antithrombin BM), thus requiring higher heparin concentration for full thrombin inhibitor function, and lower ionic strength for elution from a heparin sepharose column. In these respects it resembles "heparin cofactor A", which is, however, characterized by a substantially larger molecular weight. From AT III, AT BM further differs in its absolute dependency on the presence of heparin(oids) for antithrombin activity, in its more pronounced inhibitory specificity largely restricted to thrombin, and in the absence of substantial immunological crossreaction with antibody to AT III. Based on comparative measurements of antithrombin activity in the presence of different amounts of heparin, up to 40% of the antithrombin activity present in human blood may be attributed to AT BM. The in vivo role of this new inhibitor remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6175043     DOI: 10.1016/0049-3848(82)90237-7

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  6 in total

1.  Inhibition of chymotrypsin by heparin cofactor II.

Authors:  F C Church; C M Noyes; M J Griffith
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

2.  Modulation of heparin cofactor II activity by histidine-rich glycoprotein and platelet factor 4.

Authors:  D M Tollefsen; C A Pestka
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

3.  A new member of the plasma protease inhibitor gene family.

Authors:  H Ragg
Journal:  Nucleic Acids Res       Date:  1986-01-24       Impact factor: 16.971

4.  Isolation and properties of two forms of thrombin inhibitor from the nymphs of the camel tick Hyalomma dromedarii (Acari: Ixodidae).

Authors:  M A Ibrahim; A H Ghazy; T Maharem; M Khalil
Journal:  Exp Appl Acarol       Date:  2001       Impact factor: 2.132

5.  Non-enzymatic glycation reduces heparin cofactor II anti-thrombin activity.

Authors:  A Ceriello; E Marchi; M Barbanti; M R Milani; D Giugliano; A Quatraro; P Lefebvre
Journal:  Diabetologia       Date:  1990-04       Impact factor: 10.122

6.  Inhibition by heparin-modulated antithrombin III of amidolysis catalysed by m beta-acrosin.

Authors:  W F Long; F B Williamson
Journal:  Biochem J       Date:  1984-02-01       Impact factor: 3.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.